 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This indicator may be signaling INZY's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

Inozyme Pharma (INZY, $4.9) entered Uptrend as Momentum indicator ascends above 0 level on Sep 20, 2023

Company to share interim data updates from ongoing Phase 1/2 trials of INZ-701 in adults with ENPP1 Deficiency and ABCC6 Deficiency (PXE)BOSTON, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Inozyme Pharma...

Inozyme Pharma to Host Virtual Investor and Analyst Event on Sep. 26, 2023

In trading on Monday, shares of Inozyme Pharma Inc (INZY) crossed below their 200 day moving average of 4.18, changing hands as low as 4.11 per share. Inozyme Pharma Inc shares are...

Inozyme Pharma (INZY) Shares Cross Below 200 DMA

For the last three days, A.I.dvisor has detected that INZY's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Inozyme Pharma (INZY, $4.38) Aroon Indicator entered a Downtrend on September 14, 2023.

Inozyme Pharma (INZY, $4.28) Aroon Indicator entered a Downtrend on September 13, 2023.

This is a Bearish indicator signaling INZY's price could decline from here. Traders may explore shorting the stock or put options...

Inozyme Pharma (INZY, $4.28) Moving Average Convergence Divergence (MACD) Histogram turned negative on September 13, 2023

This is a signal that INZY's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...

Inozyme Pharma (INZY, $4.28) RSI Indicator left the oversold zone on September 13, 2023

Inozyme Pharma (INZY, $4.7) Aroon Indicator entered a Downtrend on September 12, 2023.

Inozyme Pharma (INZY, $4.77) Aroon Indicator entered a Downtrend on September 11, 2023.

Inozyme Pharma (INZY, $4.82) Aroon Indicator entered a Downtrend on September 08, 2023.

Inozyme Pharma, Inc. is a clinical-stage rare disease biopharmaceutical company. It engages in the business of developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company was founded by Axel Bolte, Joseph P. Schlessinger, and Demetrios T. Braddock in September 2015 and is headquartered in Boston, MA.

Watchers	882
52-Wk Low	$0.991
52-Wk High	$7.33

Market Cap	$283.96M
Volume (M)	541,826.00
52-Wk High	$7.33
52-Wk Low	$0.991

INZY Inozyme Pharma Inc

About

Feed

News

Sentiment

Earnings

Fundamentals